These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 15196646)

  • 1. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
    Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T
    Pharmazie; 2001 Dec; 56(12):949-52. PubMed ID: 11802658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
    Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z
    Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation design of a novel fast-disintegrating tablet.
    Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K
    Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
    Keleb EI; Vermeire A; Vervaet C; Remon JP
    Int J Pharm; 2004 Apr; 273(1-2):183-94. PubMed ID: 15010142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of binder type and concentration on the physical characteristics of calcium carbonate granules and their corresponding tablets.
    Elsabbagh HM; Ghanem AH; Abdel-Alim HM
    Pharmazie; 1981 Aug; 36(8):548-51. PubMed ID: 7291287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
    Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
    Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.